Altele acum 19 ore

Eli Lilly Receives US Approval for Oral Weight-Loss Drug

Eli Lilly has secured approval in the United States for its new weight-loss drug, available in pill form. This marks a significant advancement in the treatment of obesity and related health conditions.

Altele acum 1 zi

Eli Lilly to Acquire Centessa Therapeutics for $7.8 Billion

Eli Lilly is set to acquire Centessa Therapeutics for $7.8 billion, bolstering its drug development pipeline. The acquisition provides Eli Lilly with access to Centessa's portfolio of promising drug candidates.